MedTrace Logo

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry

NCT01422837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 403

Last updated 2018-11-16

No results posted yet for this study

Summary

The objective of the VIVITROL Registry is to gather real world data on opioid dependence and to provide understanding of the health economics of opioid dependence.

Conditions

  • Opioid Dependence

Sponsors & Collaborators

  • Alkermes, Inc.

    lead INDUSTRY

Principal Investigators

  • Alkermes Medical Director · Alkermes, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01422837 on ClinicalTrials.gov